The Two Great Myths of Social Security Reform How the debate about Social Security misses the mark. John Rekenthaler Feb 7, 2024
Bonds Are Still Too Expensive Their relative yields have become acceptable, but that’s not the whole story. John Rekenthaler Feb 5, 2024
Should ESG Investing Be Criminalized? The question, regrettably, is not a joke. John Rekenthaler Jan 31, 2024
Covered-Call Funds: A Mystery Wrapped in an Enigma These funds can perform well, but it’s hard to predict under what conditions. John Rekenthaler Jan 25, 2024
Covered-Call Stock Funds Like JEPI Are Popular. Should They Be? High distributions from these funds don’t tell the whole story. John Rekenthaler Jan 22, 2024
Skipping Your Morning Coffee Won’t Make You a Millionaire As fables go, however, this one is relatively useful. John Rekenthaler Jan 12, 2024
Stocks Have Not Always Beaten Bonds. Should You Care? How relevant are the experiences of other countries and other eras? John Rekenthaler Jan 11, 2024
Do Stocks Really Make Sense for the Long Run? New research threatens the conventional wisdom. John Rekenthaler Jan 8, 2024
Want to Lose Your Money? Listen to Millionaires. Along with anybody else who attempts to forecast the investment future. John Rekenthaler Jan 4, 2024
What Dave Ramsey and Suze Orman Can (and Cannot) Accomplish Their advice suits workers better than retirees. John Rekenthaler Dec 29, 2023
What Has Been Manhattan’s Return? Assessing Peter Minuit’s fabled $24 investment. John Rekenthaler Dec 22, 2023
Chinese Stocks: What Went Wrong A bad start, then a missed opportunity. John Rekenthaler Dec 20, 2023
3 Lessons from Stocks’ Round Trip Equities are back where they started this time last year — sort of. John Rekenthaler Dec 18, 2023
The Target-Date Fund Problem That Indexing Can’t Solve There will always be asset allocation losers (and winners). John Rekenthaler Dec 14, 2023